These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 25459048)

  • 1. Kounis syndrome manifesting as coronary aneurysm and very late coronary stent thrombosis.
    Hoshi T; Sato A; Akiyama D; Kawabe M; Hiraya D; Aonuma K
    JACC Cardiovasc Interv; 2014 Nov; 7(11):e173-6. PubMed ID: 25459048
    [No Abstract]   [Full Text] [Related]  

  • 2. Very late stent thrombosis 5 years after implantation of a sirolimus-eluting stent observed by angioscopy and optical coherence tomography.
    Ishihara T; Awata M; Fujita M; Watanabe T; Iida O; Ishida Y; Nanto S; Uematsu M
    JACC Cardiovasc Interv; 2013 May; 6(5):e28-30. PubMed ID: 23702022
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary artery aneurysms after sirolimus-eluting stent implantation: multimodality imaging evaluation.
    Fujino Y; Attizzani GF; Nakamura S; Costa MA; Bezerra HG
    JACC Cardiovasc Interv; 2013 Apr; 6(4):423-4. PubMed ID: 23597611
    [No Abstract]   [Full Text] [Related]  

  • 4. Right coronary artery 'diverticulosis' 4 years after sirolimus-eluting stent implantation associated with very late stent thrombosis.
    Good RI; Kalra S; Lee TC
    Heart; 2013 Nov; 99(21):1627. PubMed ID: 23749781
    [No Abstract]   [Full Text] [Related]  

  • 5. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent failure due to simultaneous aggressive neoatherosclerosis of first- and current-generation drug-eluting stents.
    Komukai K; Bernelli C; Sirbu V; Guagliumi G
    EuroIntervention; 2015 Nov; 11(7):e1-2. PubMed ID: 26603864
    [No Abstract]   [Full Text] [Related]  

  • 7. In-stent thin-cap fibroatheroma after drug-eluting stent implantation: ex-vivo evaluation of optical coherence tomography and intracoronary angioscopy.
    Fujii K; Hao H; Imanaka T; Kawano T; Takayama T; Hirayama A; Yamada T; Ishibashi-Ueda H; Hirota S; Masuyama T
    JACC Cardiovasc Interv; 2014 Apr; 7(4):446-7. PubMed ID: 24656539
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of Endeavor zotarolimus-eluting stent implantation for the treatment of very late stent thrombosis with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation.
    Kakefuda Y; Sato A; Watabe H; Aihara H; Nishina H; Noguchi Y; Hoshi T; Aonuma K
    Heart Vessels; 2016 Jul; 31(7):1196-9. PubMed ID: 26219730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery aneurysms and late stent thrombosis after sirolimus-eluting stent placement.
    Cano-García M; Bullones-Ramírez JA; Muñoz-Jiménez LD; Sánchez-González C; Álvarez-Rubiera J; Urbano-Carrillo CA
    Coron Artery Dis; 2016 Jun; 27(4):337-40. PubMed ID: 27110646
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple interstrut cavities: a potential mechanism for very late stent thrombosis? Insights from optical coherence tomography.
    Jama A; Prasad A
    JACC Cardiovasc Interv; 2012 Sep; 5(9):995-6. PubMed ID: 22995888
    [No Abstract]   [Full Text] [Related]  

  • 11. Time does not heal all wounds: very late stent thrombosis eight years after implantation of a sirolimus-eluting stent due to positive remodelling, saccular evaginations and marked vascular inflammation.
    Orban M; Joner M; Riegger J; Steigerwald K; Tada T; Ibrahim T; Laugwitz KL; Byrne RA; Kastrati A; Massberg S
    EuroIntervention; 2013 Jul; 9(3):412-3. PubMed ID: 23034199
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of very late stent thrombosis after drug-eluting stent implantation: findings from coronary angioscopy and optical coherence tomography.
    Ikenaga H; Ishihara M; Dai K; Nakama Y; Ohtani T
    JACC Cardiovasc Imaging; 2011 Nov; 4(11):1217-9. PubMed ID: 22093273
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study.
    Guagliumi G; Capodanno D; Saia F; Musumeci G; Tarantini G; Garbo R; Tumminello G; Sirbu V; Coccato M; Fineschi M; Trani C; De Benedictis M; Limbruno U; De Luca L; Niccoli G; Bezerra H; Ladich E; Costa M; Biondi Zoccai G; Virmani R;
    JACC Cardiovasc Interv; 2014 Sep; 7(9):958-68. PubMed ID: 25129664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very late stent thrombosis in everolimus-eluting stent with predisposing mechanical factors: Differential features.
    Jaguszewski MJ; Cortes C; Daucher H; Schincariol M; Halejcio M; Besuch P; Gutiérrez-Chico JL
    Cardiol J; 2017; 24(4):345-349. PubMed ID: 28831778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary edema demonstrated by cardiovascular magnetic resonance in patients with peri-stent inflammation and aneurysm formation after treatment by drug-eluting stents.
    Holm NR; Kim WY; Maeng M; Thrysøe SA; Bøtker HE; Thuesen L; Høyer S; Tu S; Falk E; Lassen JF; Nielsen PH; Christiansen EH
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):352-4. PubMed ID: 23512782
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
    Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
    Nishinari M; Shimohama T; Tojo T; Shiono T; Shinagawa H; Kameda R; Aoyama N; Izumi T
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E871-8. PubMed ID: 23873677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.